Changes are happening - please bear with us while we update our site.

Changes are happening - please bear with us while we update our site. Click here to give us your advice and feedback.

Mesoblast Ltd (ASX:MSB)

Pharmaceuticals, Biotechnology & Life Sciences

Mesoblast Ltd (ASX:MSB) is a leader in providing allogeneic (off the shelf) cellular medicines. It owns a portfolio of late-stage product candidates with three product candidates in Phase 3 trials, being acute graft versus host disease, chronic heart failure and chronic low back pain due to degenerative disc disease. The company has facilities in Melbourne, New York, Singapore and Texas and is listed on the ASX and the NASDAQ.

Mesoblast Ltd (ASX:MSB) share price

Mesoblast Ltd (ASX:MSB) share price news

ASX Bank Shares
James Dunn

Market shrugs off iron ore worries

The S&P/ASX 200 (INDEXASX: XJO) Index rose 8.3 points, or 0.1 per cent, to 7,712.5 on Tuesday, while the broader All Ordinaries (INDEXASX: XAO) rose 9.4 points, or 0.1 per cent, to 7,973.

Skip to content